Drug Database
Back to search

Italy· 039836010

MIRTAZAPINA AUROBINDO

A mirtazapine product containing mirtazapina, registered in Italy by AUROBINDO PHARMA ITALIA S.R.L., on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC N06AX11

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedMIRTAZAPINA AUROBINDOATCN06AX11REGISTER NO.039836010PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mirtazapinaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mirtazapine is registered in 18 of 19 countries.

Countries holding a registration under ATC N06AX11 (mirtazapine), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 11 of them publish a price we can compare per daily dose
Search mirtazapine products by name

Mirtazapine · ATC N06AX11

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mirtazapine costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.22 in France to $1.40 in Switzerland — a ×6.4 gap.

  • Italy: $0.61 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Mirtazapine · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.40
  • IT Italy$0.61
  • FR France$0.22
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Mirtazapina
Manufacturer
AUROBINDO PHARMA ITALIA S.R.L.
Country
Italy (IT)
ATC code
N06AX11
ATC class
Mirtazapine
Defined daily dose
30 mg, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    039836010
    "30 MG COMPRESSE ORODISPERSIBILI" 30 COMPRESSE IN BLISTER PA/AL/PVC/CARTA/POLIESTERE/AL
    EUR 16.17

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

482 interactions on record for mirtazapine.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check mirtazapine against other medicinesHow interaction checks work

Mirtazapine · interactions on record

482 records

  • 50 severe
  • 234 moderate
  • 2 minor
  • 162 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

34 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N06AX11

Mirtazapine, as other registers publish it.

All mirtazapine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/48f7d08b-7c03-4cd5-85e1-5354c4e4b101
GET /v1/drugs/48f7d08b-7c03-4cd5-85e1-5354c4e4b101?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"30 MG COMPRESSE ORODISPERSIBILI\" 30 COMPRESSE IN BLISTER PA/AL/PVC/CARTA/POLIESTERE/AL",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Mirtazapina",
  "reference_pack": "30 UNITA' 30 MG - USO ORALE",
  "public_price_eur": 16.17,
  "ssn_reference_price_eur": 16.17
}
API referenceMCP serverPlans

See everything about mirtazapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console